Marshall Wace North America’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-34,835	Closed	-$780K	–	1586
2020 Q3	$780K	Buy	+34,835	New	+$780K	0.01%	868